Cannabis Sativa, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 23, 2021 at 04:03 pm EDT
Share
Cannabis Sativa, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 506,889 compared to USD 708,504 a year ago. Operating loss was USD 489,935 compared to USD 289,633 a year ago. Net loss was USD 460,508 compared to USD 490,106 a year ago. Basic loss per share was USD 0.01 compared to USD 0.02 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, sales was USD 989,239 compared to USD 1.185 million a year ago. Operating loss was USD 962,616 compared to USD 870,619 a year ago. Net loss was USD 880,498 compared to USD 1.106 million a year ago. Basic loss per share was USD 0.03 compared to USD 0.05 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.04 a year ago.
Cannabis Sativa, Inc. is engaged in telehealth through its 51% owned subsidiary and the licensing of cannabis-related intellectual property (IP), marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. It operates through various subsidiaries, including PrestoCorp, Inc. (PrestoCorp), Wild Earth Naturals, Inc., Kubby Patent and Licenses Limited Liability Company, Hi Brands, International, Inc., Eden Holdings LLC, and iBudtender, Inc., GK Manufacturing and Packaging, Inc. PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoCorp uses video conferencing technology to provide a safe and confidential forum for the doctor patient interview in accordance with state regulations governing issuance of medical marijuana cards. It offers services in California, Nevada, New York, Missouri, and Oklahoma.
CANNABIS SATIVA, INC. 
